Minimize Uncertainty – Make Informed Decisions – Succeed

Cell_Gene_Therapy

Cell and Gene Therapy Today—November 20, 2025

November 20, 2025Familial chylomicronemia syndrome,Charcot Marie Tooth disease type 1A,AAV,REQORSA,Duchenne Muscular Dystrophy,Subretinal delivery,Elevidys,Redempio,BioPharma and Tech News,Plozasiran,CAR T,Liraltagene autoleucel,neuroblastoma,Tecentriq,Cell and Gene Therapy News,ADA-SCID,lentiviral gene therapy,siRNA,WaskyraWiskott Aldrich syndrome,Diabetic macular edema

This weekly Cell & Gene Therapy update spans regulatory actions, durable…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Tempest Therapeutics and Factor Bioscience dual-CAR T deal

November 20, 2025Oncology,clinical trials,market access,Regulatory,Cell Therapy,CAR T,biopharma,Lucid Diligence Brief,payer access,diligencecorporate transactions

Lucid Diligence Brief: Tempest Therapeutics and Factor Bioscience dual-CAR T…

by Timos Papagatsias

Neuroscience

Neuroscience Today — November 19, 2025

November 19, 2025migraine,multiple sclerosis,Alzheimer's Disease,pfizer,Sandoz,BioPharma and Tech News,als,Parkinson's Disease,Lundbeck,Neuroscience NewsVyepti,rimegepant

This week’s neuroscience news brings you the most important developments,…

by LucidQuest

Immunology

Immunology Video Recap—November 19, 2025

November 19, 2025NATRON,sNDA,Atopic Dermatitis,Tralokinumab,BioPharma and Tech News,TREMFYA,eczema,NICE,Immunology News,Dupixent,EC,IBS-C pediatric,HES,PsA,Pediatric psoriasissBLA,Delgocitinib

This biweekly immunology video brings you key highlights from across the…

by LucidQuest

Immunology

Immunology Today—November 19, 2025

November 19, 2025Systemic JIA,Azurity,leo pharma,Tegoprazan,Celltrion,Agomab,BioPharma and Tech News,Ontunisertib,Sebela,ALK5,TREMFYA,TGF beta,Rituximab,FS Crohn’s,Arcutis,STENOVA,Immunology News,Remsima IV liquid,guselkumab,Infliximab,PsA,ARRECTOR,Pediatric psoriasis,sNDATralokinumab,ADHAND

This weekly Immunology newsletter features late-phase efficacy readouts,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Avanzanite Bioscience €32m Series A

November 19, 2025Europe,market access,EMA,rare diseases,biopharma,Lucid Diligence Brief,payer access,diligence,venture financing,EU regulatorycommercial launches

Lucid Diligence Brief: Avanzanite Bioscience €32m Series A Professional…

by Timos Papagatsias

Artificial_Intelligence

AI in Healthcare and Digital Health Video Recap—November 18, 2025

November 18, 2025michael burry,pfizer,Insilico Medicine,BioPharma and Tech News,Eli Lilly,OpenAI,European Commission,AI in Healthcare and Digital Health,OpenEvidence,american college of cardiology,xtalpi,ailux,american medical associationoracle,meta

Here’s your biweekly AI in Healthcare and Digital Health video brief on…

by Timos Papagatsias

Obesity Weekly News

Obesity Today—November 18, 2025

November 18, 2025wegovy,semaglutide,pfizer,BioPharma and Tech News,obesity,Novo Nordisk,Tirzepatide,Zepbound,Eli Lilly,type 2 diabetesGLP-1 receptor agonist,Obesity News

Weekly Obesity update featuring major pipeline moves, regulatory and access…

by LucidQuest

Endocrinology

Endocrinology Video Recap—November 18, 2025

November 18, 2025Avant Technologies,SGAustria,sanofi,Fracture risk,BioPharma and Tech News,hypoparathyroidism,osteoporosis,type 2 diabetes,type 1 diabetes,menopause,Autoantibodies,Endocrinology News,G6PD deficiency,hba1c,Peripheral artery diseaseDiabetes UK,HMC Qatar

This biweekly endocrinology roundup covers new clinical guidelines, major…

by LucidQuest

Endocrinology

Endocrinology Today—November 18, 2025

November 18, 2025BioPharma and Tech News,thyroid cancerhypoparathyroidism,type 1 diabetes,Teplizumab,Metformin,Sun Pharma,Endocrinology News,Peripheral artery disease,Diabetic retinopathy,Menopause hormone therapy,Dexcom

Weekly Endocrinology update spotilighting regulatory developments, clinical…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics

November 18, 2025Oncology,clinical trials,Regulatory,prostate cancer,biopharma,Lucid Diligence Brief,payer access,diligence,M&A,induced proximitysmall molecules

Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics…

by Timos Papagatsias

Onco_background

Oncology Today—November 17, 2025

November 17, 2025BioPharma and Tech News,NSCLCCAR T Therapy,ADC,Bristol Myers Squibb,Oncology News,IDH-mutant glioma,GEP-NETs,metastatic colorectal cancer,radiopharmaceuticals,EGFR/HER3,glioma trial design

This week in oncology, we spotlight the most relevant updates, approvals, and…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.